Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

BGXX

Bright Green (BGXX)

Bright Green Corporation
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:BGXX
DatumZeitQuelleÜberschriftSymbolFirma
27/12/202415h30GlobeNewswire Inc.LYNN STOCKWELL ENTERS INTO A RESTRUCTURING SECURITY AGREEMENT (“RSA”) WITH BRIGHT GREEN CORPORATION AND ASSUMES THE ROLE OF EXECUTIVE CHAIR AND CEO.NASDAQ:BGXXBright Green Corporation
19/11/202423h20Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BGXXBright Green Corporation
18/11/202415h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BGXXBright Green Corporation
14/11/202415h45Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:BGXXBright Green Corporation
19/09/202419h56GlobeNewswire Inc.Bright Green Corporation Provides an Update, Reinforces Commitment to Shareholders, and Focuses on Growth and Strategic PartnershipsNASDAQ:BGXXBright Green Corporation
18/09/202423h09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BGXXBright Green Corporation
18/09/202421h17Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:BGXXBright Green Corporation
09/09/202422h05Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:BGXXBright Green Corporation
23/08/202416h00GlobeNewswire Inc.BRIGHT GREEN EMBARKS ON MAJOR PARTNERSHIP WITH BENUVIA OPERATIONS, LLC. WILL SUPPLY PHARMA EXPERT WITH AMERICAN MADE RAW MATERIALS FROM ITS INDUSTRY LEADING AND DEA-APPROVED SCH I & II DRUG FACILITY.NASDAQ:BGXXBright Green Corporation
21/08/202416h02GlobeNewswire Inc.BRIGHT GREEN EMBARKS ON MAJOR PARTNERSHIP WITH BENUVIA PHARMACEUTICALS. WILL SUPPLY PHARMA EXPERT WITH AMERICAN MADE RAW MATERIALS FROM ITS INDUSTRY LEADING AND DEA-APPROVED SCH I & II DRUG FACILITY.NASDAQ:BGXXBright Green Corporation
19/08/202423h15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BGXXBright Green Corporation
19/08/202423h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BGXXBright Green Corporation
15/08/202423h00Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:BGXXBright Green Corporation
08/08/202422h51GlobeNewswire Inc.BRIGHT GREEN ANNOUNCES IT HAS OBTAINED A $3.5 MILLION FUNDING COMMITMENT UNDER AN EXISTING LINE OF CREDIT AND HAS ENGAGED AN INVESTMENT BANK TO SEEK A $15.0 MILLION DEBT FINANCING TO MOVE FORWARD WITH COMMERCIALIZATION.NASDAQ:BGXXBright Green Corporation
10/06/202415h15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BGXXBright Green Corporation
30/05/202423h08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BGXXBright Green Corporation
30/05/202416h06GlobeNewswire Inc.CEO UPDATENASDAQ:BGXXBright Green Corporation
29/05/202400h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BGXXBright Green Corporation
29/05/202400h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BGXXBright Green Corporation
29/05/202400h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BGXXBright Green Corporation
20/05/202422h05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BGXXBright Green Corporation
16/05/202414h30Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:BGXXBright Green Corporation
14/03/202414h00GlobeNewswire Inc.BRIGHT GREEN ANNOUNCES ITS EXPANSION CONTINUATION WITH A $100 MILLION SOLAR POWERED GENERATION FIELD TO SUPPLY HEAT AND ELECTRICITY TO ITS DRUG PRODUCTION AND MANUFACTURING FACILITY.NASDAQ:BGXXBright Green Corporation
12/03/202415h59GlobeNewswire Inc.BRIGHT GREEN ANNOUNCES PLANS FOR $250 MILLION EXPANSION OF ITS CONTROLLED SUBSTANCES DRUG PRODUCTION FACILITY IN GRANTS, NEW MEXICO AND OBTAINS $60 MILLION IN FINANCINGNASDAQ:BGXXBright Green Corporation
11/03/202421h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BGXXBright Green Corporation
07/03/202414h00GlobeNewswire Inc.Bright Green Corporation (BGXX) submits for historic DEA Registration for Production of Schedule I and Schedule II controlled substances.NASDAQ:BGXXBright Green Corporation
22/02/202423h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BGXXBright Green Corporation
22/02/202419h30GlobeNewswire Inc.BRIGHT GREEN CORPORATION GAINS MOMENTUM FOR THEIR “DRUGS MADE IN AMERICA” PLATFORM WITH APPROVAL FOR THE RESEARCH, PRODUCTION AND MANUFACTURING OF ALL SCHEDULE I AND SCHEDULE II PLANT-BASED DRUGSNASDAQ:BGXXBright Green Corporation
20/02/202422h31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BGXXBright Green Corporation
20/02/202422h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BGXXBright Green Corporation
 Showing the most relevant articles for your search:NASDAQ:BGXX

Kürzlich von Ihnen besucht